ESR1 and breast cancer: In the current study, we performed IHC analyses on ER– breast cancer biopsies to determine whether the spatial distribution of tumor NOS2 and COX2 contributes to immune-suppressive mechanisms involving TRegs, PD1/PDL1, IDO1, and B7H4 to suppress T effector (TEff) cell function.